BR9609920A - Uso de griseofulvina para inibir o crescimento de cânceres - Google Patents

Uso de griseofulvina para inibir o crescimento de cânceres

Info

Publication number
BR9609920A
BR9609920A BR9609920A BR9609920A BR9609920A BR 9609920 A BR9609920 A BR 9609920A BR 9609920 A BR9609920 A BR 9609920A BR 9609920 A BR9609920 A BR 9609920A BR 9609920 A BR9609920 A BR 9609920A
Authority
BR
Brazil
Prior art keywords
griseofulvin
cancer growth
inhibit cancer
inhibit
growth
Prior art date
Application number
BR9609920A
Other languages
English (en)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9609920A publication Critical patent/BR9609920A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9609920A 1995-08-03 1996-07-30 Uso de griseofulvina para inibir o crescimento de cânceres BR9609920A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US67418196A 1996-07-16 1996-07-16
PCT/US1996/012475 WO1997005870A2 (en) 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers

Publications (1)

Publication Number Publication Date
BR9609920A true BR9609920A (pt) 1999-07-06

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609920A BR9609920A (pt) 1995-08-03 1996-07-30 Uso de griseofulvina para inibir o crescimento de cânceres

Country Status (16)

Country Link
EP (1) EP0841914A2 (pt)
JP (1) JPH11511136A (pt)
KR (1) KR19990036137A (pt)
AR (1) AR003176A1 (pt)
AU (1) AU713031B2 (pt)
BR (1) BR9609920A (pt)
CA (1) CA2228503A1 (pt)
CZ (1) CZ30598A3 (pt)
HU (1) HUP9903506A3 (pt)
IL (1) IL123094A0 (pt)
MX (1) MX9800945A (pt)
NO (1) NO980420L (pt)
PL (1) PL324905A1 (pt)
SK (1) SK14298A3 (pt)
TR (1) TR199800244T2 (pt)
WO (1) WO1997005870A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1098641B1 (en) * 1998-07-27 2016-04-27 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
EP1949910A1 (en) 1998-11-09 2008-07-30 Biogen Idec, Inc. Treatment of chronic lymphocytic leukemia (CLL) using chimeric anti-CD20 antibody.
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
PT1407784E (pt) * 2001-06-25 2011-03-03 Ajinomoto Kk Agentes antitumorais
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
MX9800945A (es) 1998-04-30
SK14298A3 (en) 1998-09-09
NO980420D0 (no) 1998-01-30
WO1997005870A2 (en) 1997-02-20
NO980420L (no) 1998-04-03
CZ30598A3 (cs) 1998-06-17
KR19990036137A (ko) 1999-05-25
AU6683496A (en) 1997-03-05
AR003176A1 (es) 1998-07-08
WO1997005870A3 (en) 1997-04-17
AU713031B2 (en) 1999-11-18
CA2228503A1 (en) 1997-02-20
HUP9903506A3 (en) 2000-07-28
EP0841914A2 (en) 1998-05-20
IL123094A0 (en) 1998-09-24
HUP9903506A2 (hu) 2000-06-28
PL324905A1 (en) 1998-06-22
TR199800244T2 (xx) 1998-09-21
JPH11511136A (ja) 1999-09-28

Similar Documents

Publication Publication Date Title
BR9609920A (pt) Uso de griseofulvina para inibir o crescimento de cânceres
LV11895A (lv) 4-benzoilpirazola atvasinajumi un to pielietojums par herbicidiem
DE69630311D1 (de) Verminderung des haarwuchses
BR9611502A (pt) Uso de epinastina para o tratamento de dor
DE69617652D1 (de) Verminderung des haarwuchses
BR9702049A (pt) Uso de composiç es compreendendo composfos biologicamente eficazes estabilizados
BR9609154A (pt) Uso de linhagens de célula fetais neuro-derivadas para terapia de transplante
BR9707425A (pt) Composto processo terapêutico para inibir o crescimento de células cancerosas e processo para utilizar o composto
DE69413815D1 (de) Inhibierung des Haarwuchses
DE69726001D1 (de) Verminderung des haarwuchhses
DE69427756D1 (de) Hemmung des haarwachstum
BR9609022A (pt) Benzotriazóis de fórmula (I) processo para a preparação de benzotriazóis de fórmula (I) composições micro - biocidas uso de benzotriazóis de fórmula (I) processo para controlar microorganismos indesejáveis e pro - cesso para a preparação de composições microbiocidas
BR9707501A (pt) Composto composição farmacêutica e uso do composto
BR9610234A (pt) Uso de lipídeos
DE69825607D1 (de) Verminderung des haarwuchses
BR9711296A (pt) Composto processo terap-utico para inibir o crescimento de c-lulas de c ncer e composi-Æo farmac-utica
DE69720053D1 (de) Verminderung des haarwuchses
BR9510141A (pt) Composição aquosa para fixar o cabelo
BR9604950A (pt) Composição farmacêutica contendo n-clorofenil carbamatos n-clorofeniltiocarbamatos e derivados de n-fosfonoglicina para inibir o crescimento de cânceres e vírus em mamíferos
NO980473D0 (no) Anvendelse av flukonazol for å inhibere cancervekst
ITMI931306A1 (it) Procedimento microbico per la preparazione di mevinolina
PT897667E (pt) Composicao para melhorar o pao
IT1276799B1 (it) Formulazioni di f-silicone
ITMI913127A0 (it) Composizioni per uso dermatologico e cosmetico
BR9606856A (pt) Uso dermatológico de derívados de vitamina d

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]